Skin Science

Collagen and skin health: what the science actually supports

The collagen market is worth tens of billions. The evidence is considerably thinner than the marketing. Here's what works, what probably works, and what doesn't.

← Back to Quellmark

Collagen is the most abundant protein in the human body — approximately 30% of total protein mass. In skin, it provides tensile strength and is responsible for the structural integrity that gives skin its resilience. From the third decade onward, dermal collagen synthesis declines at approximately 1% per year, while collagen degradation increases due to cumulative UV exposure, oxidative stress, and glycation. The visual result is what people broadly call skin ageing.

The question is not whether collagen decline matters — it does. The question is what, if anything, can meaningfully modify the trajectory.

What the collagen supplement evidence actually shows

Oral collagen supplementation has a plausible mechanism: hydrolysed collagen peptides (broken into di- and tripeptides during digestion) are absorbed intact and have been detected in skin tissue in tracer studies. They may stimulate fibroblast activity — the cells responsible for collagen synthesis — by acting as signalling molecules.

The evidence is more positive than it was five years ago. A 2023 systematic review and meta-analysis in the International Journal of Dermatology (26 RCTs, n=1,721) found that oral collagen supplementation produced statistically significant improvements in skin hydration, elasticity, and self-reported wrinkle appearance over 8–24 weeks. Effect sizes were modest (5–15% improvement over placebo), and the majority of trials were funded by supplement manufacturers — which is a systematic bias worth noting.

The methodological honest answer: Oral collagen supplementation likely provides a small but real benefit to skin hydration and elasticity in adults over 35. The evidence quality is improving. The effect size is meaningful enough to justify use for people specifically targeting skin outcomes, but it should not be treated as equivalent to what's achieved by addressing the primary drivers (sun protection, vitamin C status, sleep quality, blood glucose control).

The primary drivers most people underestimate

Ultraviolet exposure is the single largest modifiable driver of skin ageing. UV-A and UV-B radiation activate matrix metalloproteinases (MMPs) — enzymes that directly degrade collagen fibres — while simultaneously generating reactive oxygen species that damage fibroblasts. The cumulative effect of daily incidental exposure (windows, commuting, brief outdoor time) over decades accounts for the majority of visible facial ageing in most adults. Consistent broad-spectrum SPF 30+ is the intervention with the largest evidence base for preventing collagen degradation.

Vitamin C is required for collagen synthesis — it's a cofactor for the hydroxylation of proline and lysine, which are essential for collagen cross-linking and structural stability. Vitamin C deficiency (even marginal deficiency) impairs collagen synthesis regardless of substrate availability. Topical vitamin C in a stable, penetrating formulation (L-ascorbic acid at pH 2.5–3.5, 10–20% concentration) has the strongest evidence base of any topical ingredient for stimulating dermal collagen synthesis and has additive effects with sun protection.

Blood glucose control is underappreciated as a skin ageing driver. Advanced glycation end-products (AGEs) form when glucose binds to proteins including collagen, creating cross-links that reduce collagen flexibility and increase brittleness. This process accelerates with elevated blood glucose. The visible result is accelerated skin ageing that correlates more strongly with metabolic health than most people realise. This is one of the mechanisms by which individuals with well-controlled metabolic health tend to have younger-looking skin at equivalent chronological ages.

Sleep quality influences collagen via growth hormone. GH is the primary stimulus for collagen synthesis in dermal fibroblasts, and GH release is concentrated in slow-wave sleep. Chronically poor sleep — whether through inadequate duration or disrupted architecture — reduces the nocturnal GH pulse and, by extension, the skin's main anabolic signal.

Topicals with meaningful evidence

What doesn't work (at scale)

Collagen creams and serums: Collagen molecules are too large to penetrate the stratum corneum. Topical collagen provides surface hydration via occlusion, not dermal delivery. This is not controversial — it's basic skin biology. A cream "with collagen" is a moisturiser.

LED devices (at home intensities): Red light at 630–700nm has genuine evidence at clinical intensities (5–40 mW/cm²). Consumer devices typically deliver 1–5 mW/cm². The dose-response relationship means that underpowered home devices are likely producing negligible collagen synthesis effects, though they may provide benefits through other pathways (inflammation, mood).

The hierarchy of interventions

For someone who has addressed nothing yet:

  1. Daily broad-spectrum SPF (this alone has the largest evidence base for slowing collagen degradation)
  2. Retinoid (tretinoin by prescription, retinol OTC)
  3. Vitamin C serum (stable L-ascorbic acid formulation)
  4. Blood glucose management and sleep quality
  5. Oral hydrolysed collagen (10–15g/day, alongside vitamin C)
  6. Niacinamide and peptide topicals

The first four items on that list will produce more visible improvement than any supplement protocol. The supplement layer is additive — genuinely useful, but not foundational.